ROL

ROL Total Assets

$3.35BQuarterly · USD

Period ending:

ROL FY Total AssetsUSD
ROL FY Total Assets1986-06-30: $117.50M1988-06-30: $131.60M1988-12-31: $146.50M1989-12-31: $160.10M1990-12-31: $178.00M1991-12-31: $204.60M1992-12-31: $236.30M1993-12-31: $267.20M1994-12-31: $295.30M1995-12-31: $314.90M1996-12-31: $308.80M1997-12-31: $432.70M1998-12-31: $327.30M1999-12-31: $312.90M2000-12-31: $298.82M2001-12-31: $296.56M2002-12-31: $317.41M2003-12-31: $349.90M2004-12-31: $418.78M2005-12-31: $439.64M2006-12-31: $453.18M2007-12-31: $475.23M2008-12-31: $572.52M2009-12-31: $566.50M2010-12-31: $619.01M2011-12-31: $645.65M2012-12-31: $692.51M2013-12-31: $739.22M2014-12-31: $808.16M2015-12-31: $852.43M2016-12-31: $916.54M2017-12-31: $1.03B2018-12-31: $1.09B2019-12-31: $1.74B2020-12-31: $1.85B2021-12-31: $2.02B2022-12-31: $2.12B2023-12-31: $2.60B2024-12-31: $2.82B2025-12-31: $3.14B$3.14B$0.00
1986-06-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ROL total assets history

Total value of everything the company owns. The available annual fiscal periods series contains 40 observations from Jun 30, 1986 to Dec 31, 2025.

Rollins, Inc. Total Assets — Annual fiscal periods (USD)
Period endingTotal Assets (USD)
3,140,523,000
2,819,695,000
2,595,460,000
2,122,028,000
2,021,540,000
1,845,900,000
1,739,392,000
1,094,124,000
1,033,663,000
916,538,000
852,431,000
808,162,000
739,217,000
692,506,000
645,650,000
619,014,000
566,496,000
572,517,000
475,228,000
453,175,000
439,637,000
418,780,000
349,904,000
317,407,000
296,559,000
298,819,000
312,900,000
327,300,000
432,700,000
308,800,000
314,900,000
295,300,000
267,200,000
236,300,000
204,600,000
178,000,000
160,100,000
146,500,000
131,600,000
117,500,000

Compare total assets

All ROL financial metrics · ROL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.